OCG
BIIB icon

Opus Capital Group’s Biogen BIIB Stock Holding History

Opus Capital Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-621
Closed -$251K – 249
2015
Q2 		$251K Sell
621
-25
-4% -$10K 0.04% 209
2015
Q1 		$273K Sell
646
-100
-13% -$39.4K 0.04% 206
2014
Q4 		$253K Sell
746
-69
-8% -$22.3K 0.04% 211
2014
Q3 		$270K Hold
815
– – 0.04% 217
2014
Q2 		$257K Sell
815
-20
-2% -$6.02K 0.02% 212
2014
Q1 		$255K Sell
835
-200
-19% -$63.5K 0.02% 186
2013
Q4 		$289K Buy
+1,035
New +$268K 0.02% 175

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Opus Capital Group's BIIB Position: Q3 2015 in Review

Opus Capital Group sold out of Biogen (BIIB) in Q3 2015, closing a stake of 621 shares — an estimated $251K sold.

Opus Capital Group first reported a position in BIIB in Q4 2013 and held it in 7 quarters. The position peaked at $289K in Q4 2013. 924 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

  • Opus Capital Group reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
  • Opus Capital Group sold 621 Biogen shares in Q3 2015, an estimated $251K.
  • Opus Capital Group first reported a position in Biogen in Q4 2013 and held it in 7 quarters.
  • Opus Capital Group's Biogen position peaked at $289K in Q4 2013.
  • 924 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on Opus Capital Group's 13F filing for Q3 2015, filed 6 Nov 2015.